cagrilintide and semaglutide 2.4 mg + Blend Semaglutide, a glucagon-like peptide-1 (GLP-1)

Advanced technology that provides you with easy access to the best doctors that you trust.

Exaggerated GLP-1 secretion underlies hyperinsulinemic #hypoglycemia in some individuals post #bariatric surgery and contributes to improved beta cell function

This patient-crafted GLP1 Symptom Tracker will help you to gain insight about your daily habits and how they are affecting your overall GLP1 journey!Crafted by a GLP1 patient, it includes metrics you won't find in a typical symptom trackers such as injection day, bathroom habits (we all know this is important on a GLP1), injection location, weekly dosage, water instake, caloric and sleep goals met, and so much more

This was an effect seen in rodent studies

batch numbers

Collectively, SGLT2i-GLP-1RA combination therapy significantly improved BP control, independent of the order in which the agents were initiated.